This is a demo store. No orders will be fulfilled.
Themes
Subscribe to RSS Feed-
30 Jan 2015  |  Global  |  Technology Alert
Genetic Technology Alert. Plazomicin Antibiotic for Treatment of CRE; Development of Recombinant Human Growth Factor Hormone; Enzyme Inhibition Therapy to Treat Obesity and Related Diseases
This issue profiles plazomicin antibiotic for treatment of CRE, development of recombinant human growth factor hormone, and an enzyme inhibition therapy to treat obesity and related diseases.
$250.00